Back to the search results

Helios Klinikum Berlin-Buch

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030-94010
Fax: 030-9401-55519
Mail: ed.tiehdnuseg-soileh@hcub-nilreb.ofni

https://www.helios-gesundheit.de/kliniken/berlin-b...
  • Number of beds: 1.223
  • Number of specialist departments: 35
  • Number of inpatient cases: 47.860
  • Number of partial inpatient cases: 1.235
  • Number of outpatient cases: 106.845
  • Hospital owners: Helios Klinikum Berlin-Buch GmbH
  • Type of provider: privat
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
Diabetes mellitus Typ 2

Quantity performed 30
Exception? No exception
Quantity performed 560
Exception? No exception
Quantity performed 113
Exception? No exception
Quantity performed 23
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 30
Quantity forecast year: 23
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 560
Quantity forecast year: 536
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 113
Quantity forecast year: 106
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 23
Quantity forecast year: 25
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 445
Quantity forecast year: 455
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ01 Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ02 Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases
CQ05 Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ28 Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)
CQ25 Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ24 Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: yes
Number Group
390 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
256 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
221 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • Measures
    • Prevention
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission
  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
  • Sonstige_elektronische_Unterstuetzung
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Andere_Massnahme
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Praktisches und theoretisches Ausbildungszentrum der MSB (Medical School Berlin) für Humanmedizin

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Explanation

Training in other healing professions
Comment

in Kooperation mit der Alice Salomon Hochschule Berlin

Comment

zusätzlich mit Vertiefung

Comment

Pflegefachassistenz / 1,5 Jahre

Comment

Comment

Comment

duales Studium Evangelische Hochschule Berlin

Comment

Ausbildung von MTL (Medizinische Technologen für Laboratoriumsanalytik) in Kooperation mit den Berufsfachschulen Lette-Verein Berlin und Gesundheitsakademie Potsdam.

Comment

Praktikumseinsätze bei Kooperationen

Comment

Ulrich Höcke

Patientenfürsprecher

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -4748-0256
Mail: ed.nilreb@mukinilksoileh-rehcerpsreufnetneitaP

Renate Bath

Patientenfürsprecherin für die Kinder- und Jugendpsychiatrie

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -4748-0256
Mail: ed.nilreb@hcub.soileh-reuftap

Manon Klamerski

Beschwerdemanagement

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-14141
Mail: ed.nekinilk-soileh@iksremalk.nonam

Helena Schäfer

Beschwerdemanagement

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-14142
Mail: ed.tiehdnuseg-soileh@refeahcS.aneleH

Dr. med. univ. Alexandra Kretzschmar

Leiterin Medizincontrolling

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-17897
Mail: ed.tiehdnuseg-soileh@ramhcszterK.ardnaxelA

Herr Prof. Dr. med. Henning Baberg

Vorsitzender

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-52900
Mail: ed.nekinilk-soileh@grebab.gninneh

Thomas Waßmann

Leiter Krankenhausapotheke

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-51300
Mail: ed.tiehdnuseg-soileh@nnamssaW.samohT

Herr Olaf Kullmann

Schwerbehindertenvertreter

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-55673
Mail: ed.tiehdnuseg-soileh@nnamlluK.falO

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030-94010
Fax: 030-9401-55519
Mail: ed.tiehdnuseg-soileh@hcub-nilreb.ofni

Sylvia Lehmann

Pflegedirektorin

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-55504
Mail: ed.tiehdnuseg-soileh@nnamheL.aivlyS

Carmen Bier

Geschäftsführerin

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-55500
Mail: ed.tiehdnuseg-soileh@reiB.nemraC

Carmen Bier

Geschäftsführerin

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-55500
Mail: ed.tiehdnuseg-soileh@reiB.nemraC

Prof. Dr. med. Henning Baberg

Ärztlicher Direktor

Schwanebecker Chaussee 50
13125 Berlin

Phone: 030 -9401-52900
Mail: ed.tiehdnuseg-soileh@grebaB.gninneH

No

IK: 261101300

Location number: 773608000

Hospital portrait for download